Get 20% Free Customization In This Report

Buy this report from - $3456

Methadone Market by Mode of Administration (Oral Medicine [Tablets and Liquid] and Injections) and Application (Operation, Detoxification, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_183607	Pages: NA	Jul 2018 \| 869 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Methadone is an opioid medication utilized for the treatment of pain and as maintenance therapy. The medication helps to reduce cravings and withdrawal symptoms in people with opioid addiction. In addition, it helps to block the high sensation in parts of the brain and spinal cord that are caused by using opiates. Methadone helps to manage additions in patient dependent to heroin, morphine, or prescription painkillers. It can be used for a short or long duration depending on the requirement of the patient.

Rise in the number of people addicted to various opioid such as heroin and morphine is a major driving factor of the market. Moreover, increase in awareness towards the use of this medication and rise in number of people seeking help to detox boost the market growth. In addition, as the medication can be used for pain management, rise in the number of people with chronic pain is expected to increase the demand for methadone. However, the side effects associated with the use of methadone restrain the market growth.

The global methadone market is segmented based on mode of administration, application, and geography. Based on mode of administration, the market is classified into oral medicine and injections. Oral medicine is further bifurcated into tablets and liquid. Based on application, the market is categorized into operation, detoxification, and other. Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Qinghai Pharm, Roxane (Boehringer Ingelheim), CentralPharm, Mallinckrodt, Macfarlan Smith, VistaPharm, Diskets, Methadoes, Aurolife Pharma LLC, and Dolophine are provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
This report entails the detailed quantitative analysis of the current market and estimations through 2017-2023, which assists to identify the prevailing market opportunities.
The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
An in-depth analysis of current research and clinical developments within market is provided with key market dynamic factors that helps understand the behavior of the market

Methadone Market Key Segments:

By Mode of Administration

Oral Medicine
- Tablets
- Liquid
Injections

By Application

Operation
Detoxification
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENTS
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

Chapter: 2EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

Chapter: 3MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.MARKET SHARE ANALYSIS, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS

3.4.1.MARKET DYNAMICS
3.4.2.Drivers
3.4.3.Restraints
3.4.4.Opportunities

Chapter: 4METHADONE MARKET, BY MODE OF ADMINISTRATION

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.ORAL MEDICINE

4.2.1.Key market trends
4.2.2.Growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Tablets
4.2.5.Liquid

4.3.INJECTIONS

4.3.1.Key market trends
4.3.2.Growth factors and opportunities
4.3.3.Market size and forecast

Chapter: 5METHADONE MARKET, BY APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.OPERATION

5.2.1.Market size and forecast

5.3.DETOXIFICATION

5.3.1.Market size and forecast

5.4.OTHERS

5.4.1.Market size and forecast

Chapter: 6METHADONE MARKET, BY GEOGRAPHY

6.1.OVERVIEW
6.2.NORTH AMERICA

6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast

6.2.3.1.U.S. market size and forecast
6.2.3.2.Canada market size and forecast
6.2.3.3.Mexico market size and forecast

6.2.4.North America Methadone Market by Mode of Administration
6.2.5.North America Methadone Market by Application

6.3.EUROPE

6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast

6.3.3.1.Germany market size and forecast
6.3.3.2.France market size and forecast
6.3.3.3.UK market size and forecast
6.3.3.4.Italy market size and forecast
6.3.3.5.Spain market size and forecast
6.3.3.6.Rest of Europe market size and forecast

6.3.4.Europe Methadone Market by Mode of Administration
6.3.5.Europe Methadone Market by Application

6.4.ASIA-PACIFIC

6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast

6.4.3.1.Japan market size and forecast
6.4.3.2.China market size and forecast
6.4.3.3.Australia market size and forecast
6.4.3.4.India market size and forecast
6.4.3.5.South Korea market size and forecast
6.4.3.6.Taiwan market size and forecast
6.4.3.7.Rest of Asia-Pacific market size and forecast

6.4.4.Asia-Pacific Methadone Market by Mode of Administration
6.4.5.Asia-Pacific Methadone Market by Application

6.5.LAMEA

6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast

6.5.3.1.Brazil market size and forecast
6.5.3.2.Turkey market size and forecast
6.5.3.3.Saudi Arabia market size and forecast
6.5.3.4.South Africa market size and forecast
6.5.3.5.Rest of LAMEA market size and forecast

6.5.4.LAMEA Methadone Market by Mode of Administration
6.5.5.LAMEA Methadone Market by Application

Chapter: 7COMPANY PROFILES

7.1.QINGHAI PHARM

7.1.1.Operating business segments
7.1.2.Business performance
7.1.3.Key strategic moves and developments

7.2.ROXANE (BOEHRINGER INGELHEIM)

7.2.1.Operating business segments
7.2.2.Business performance
7.2.3.Key strategic moves and developments

7.3.CENTRALPHARM

7.3.1.Operating business segments
7.3.2.Business performance
7.3.3.Key strategic moves and developments

7.4.MALLINCKRODT

7.4.1.Operating business segments
7.4.2.Business performance
7.4.3.Key strategic moves and developments

7.5.MACFARLAN SMITH

7.5.1.Operating business segments
7.5.2.Business performance
7.5.3.Key strategic moves and developments

7.6.VISTAPHARM

7.6.1.Operating business segments
7.6.2.Business performance
7.6.3.Key strategic moves and developments

7.7.DISKETS

7.7.1.Operating business segments
7.7.2.Business performance
7.7.3.Key strategic moves and developments

7.8.METHADOES

7.8.1.Operating business segments
7.8.2.Business performance
7.8.3.Key strategic moves and developments

7.9.AUROLIFE PHARMA LLC

7.9.1.Operating business segments
7.9.2.Business performance
7.9.3.Key strategic moves and developments

7.10.DOLOPHINE

7.10.1.Operating business segments
7.10.2.Business performance
7.10.3.Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Methadone Market by Mode of Administration (Oral Medicine [Tablets and Liquid] and Injections) and Application (Operation, Detoxification, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023